How Lifespin revolutionizes the diagnosis of diseases with metabolic information and artificial intelligence
An interview by 5-HT Digital Hub Chemistry & Health with Dr. Ali Tinazli
An interview by 5-HT Digital Hub Chemistry & Health with Dr. Ali Tinazli
lifespin’s agreement with Medical University Graz which garants access to more than 25,000 longitudinal blood samples
Dr. Ali Tinazli’s first post at the Forbes magazine about “The Bio Revolution Brings Innovation For Precision Diagnostics”
Metabolomics, an emerging clinical modality, enabling precision, personalized medicine
Metabolomics can measure the actual physiological state of an individual, providing new health insights
BOSTON (MA), April 12th, 2022 — Lifespin GmbH, a deep data company that is mapping human health and building an innovative health diagnostic testing platform based on metabolomics, announced today that it has formally established a U.S. entity, Lifespin, Inc., incorporated in Delaware, and based initially in Boston (MA) to accelerate the company’s access to …
Lifespin Establishes U.S. Corporate Entity in Anticipation of Market Expansion Read More »
Das Regensburger Unternehmen Lifespin digitalisiert Stoffwechselproben und wagt heuer den Sprung in die USA – Auch die Harvard University ist bei der Entwicklung beteiligt
Lifespin GmbH Secures €2.5M Bridge Financing to Further Build its AI-Enabled
Metabolomics-Based Differential Diagnosis Panel for Neurological Diseases
Lifespin Using NMR to Develop Metabolomics-Based Diagnostics